BREAKING NEWS
Vabysmo (faricimab, Roche), has been listed on the Pharmaceutical Benefits Scheme (PBS) for the treatment of patients with macular oedema secondary to retinal vein occlusion (RVO).
Strathfield Retina Clinic is proud to have been involved in the pivotal multinational BALATON and COMINO Clinical Research trials of Vabysmo (faricimab) in RVO over the last several years. Our team of Retina Specialists, Clinical Orthoptists and Clinical Trial Coordinators have contributed as Principal Investigators and as a major site to this forefront research with a new therapeutic agent.
For more information about involvement in new clinical trials please click here or contact us at info@strathfieldretina.com.au
Further Resources: